For a company that has been either a group leader or solidly above peer averages for quite some time, MetLife (MET)
doesn't get a lot of benefit of the doubt these days. Some of that can
be tied to the weak rate environment as well as uncertainties as to how
large insurance companies like MetLife will be regulated in the future. I
believe investors are too worried about the negatives on this name and
are underrating the growth potential of the company's overseas
businesses and the value of its strategic shift toward more
protection-oriented and less capital-intensive business. These shares
could be as much as 25% undervalued today, making it a very worthwhile
name to consider at these levels.
Continue here for the full article:
Uncertainties Weighing A Little Too Heavily On MetLife
No comments:
Post a Comment